Edgewise Therapeutics (EWTX) Capital Expenditures (2020 - 2026)
Edgewise Therapeutics (EWTX) posted Capital Expenditures of $32,000 for Q2 2026, down 36.0% from $50,000 a year earlier and down 87.7% from the prior quarter.
Powered by 
Analysis
Edgewise Therapeutics (EWTX) Capital Expenditures (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Edgewise Therapeutics was $454,000, down 48.9% year-over-year; for FY2025, it was $256,000, down 80.5% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 4.7% (FY2020 to FY2025).
- In prior years, Edgewise Therapeutics' Capital Expenditures was $1.31 million in FY2024 (-77.2%), $5.75 million in FY2023 (+3.6%), $5.55 million in FY2022 (+730.2%) and $668,000 in FY2021 (+229.1%).
- The Q2 2026 figure stands as the lowest quarterly Capital Expenditures since Q3 2020.
- On a year-over-year basis, Capital Expenditures increased in three of the last eight quarters, with growth averaging 27.5%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2022, with growth of 628.9%; the weakest was Q4 2023, with a decline of 95.1%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $260,000 (Q1 2026), $73,000 (Q4 2025) and $89,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Edgewise Therapeutics | 4.22 Bn | 4.22 Bn | - | 32,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32,000.00 |
| Mar 31, 2026 | 260,000.00 |
| Dec 31, 2025 | 73,000.00 |
| Sep 30, 2025 | 89,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Dec 31, 2024 | 274,000.00 |
| Sep 30, 2024 | 520,000.00 |
| Jun 30, 2024 | 221,000.00 |
| Mar 31, 2024 | 297,000.00 |
| Dec 31, 2023 | 161,000.00 |
| Sep 30, 2023 | 457,000.00 |
| Jun 30, 2023 | 759,000.00 |
| Mar 31, 2023 | 4.37 Mn |
| Dec 31, 2022 | 3.29 Mn |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | 554,000.00 |
| Mar 31, 2022 | 369,000.00 |
| Dec 31, 2021 | 79,000.00 |
| Sep 30, 2021 | 451,000.00 |
API Access
Edgewise Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EWTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "EWTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EWTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();